Your browser doesn't support javascript.
loading
Performance of the fixed pressure valve with antisiphon device SPHERA® in the treatment of normal pressure hydrocephalus and prevention of overdrainage.
Pereira, Renan M; Suguimoto, Mariane T; Oliveira, Matheus F; Tornai, Juliana B; Amaral, Ricardo A; Teixeira, Manoel Jacobsen; Pinto, Fernando Campos Gomes.
Afiliação
  • Pereira RM; Universidade Anhembi Morumbi, São Paulo, SP, Brazil.
  • Suguimoto MT; Universidade Anhembi Morumbi, São Paulo, SP, Brazil.
  • Oliveira MF; Departamento de Neurocirurgia, Hospital do Servidor Público Estadual de São Paulo, São Paulo, SP, Brazil.
  • Tornai JB; Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Amaral RA; Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Teixeira MJ; Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Pinto FC; Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Arq Neuropsiquiatr ; 74(1): 55-61, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26602193
Normal pressure hydrocephalus (NPH) is characterized by the triad of gait apraxia, dementia and urinary incontinence associated with ventriculomegaly and normal pressure of cerebrospinal fluid. Treatment is accomplished through the implantation of a ventricular shunt (VPS), however some complications are still frequent, like overdrainage due to siphon effect. This study analyses the performance of a valve with anti-siphon device (SPHERA®) in the treatment of patients with NPH and compares it with another group of patients with NPH who underwent the same procedure without anti-siphon mechanism (PS Medical® valve). 30 patients were consecutively enrolled in two groups with 15 patients each and followed clinically and radiologically for 1 year. Patients submitted to VPS with SPHERA® valve had the same clinical improvement as patients submitted to VPS with PS Medical®. However, complications and symptomatology due to overdrainage were significantly lower in SPHERA® group, suggesting it as a safe tool to treat NPH.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Derivação Ventriculoperitoneal / Vazamento de Líquido Cefalorraquidiano / Hidrocefalia de Pressão Normal Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Arq Neuropsiquiatr Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Derivação Ventriculoperitoneal / Vazamento de Líquido Cefalorraquidiano / Hidrocefalia de Pressão Normal Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Arq Neuropsiquiatr Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha